The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Protective effects of C5a blockade in sepsis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sepsis and septic shock—A review of laboratory models and a proposal
Wichterman, K. A., Baue, A. E., & Chaudry, I. H. (1980) · Journal of Surgical Research · doi:10.1016/0022-4804(80)90037-2 · Cited by 1,459
Bone, R. C. (1996) · Critical Care Medicine · doi:10.1097/00003246-199601000-00026 · Cited by 603
ANIMAL MODELS OF SEPSIS AND SHOCK: A REVIEW AND LESSONS LEARNED
Deitch, E. A. (1998) · Shock · doi:10.1097/00024382-199801000-00001 · Cited by 579
Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes.
Sj, K. (1975) · PubMed · Cited by 568
Wessels, M. R., Butko, P., Ma, M., Warren, H. B., Lage, A. L., & Carroll, M. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11490 · Cited by 503
Anticytokine Strategies in the Treatment of the Systemic Inflammatory Response Syndrome
Dinarello, C. A. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500140081040 · Cited by 405
THE PHLOGISTIC ROLE OF C3 LEUKOTACTIC FRAGMENTS IN MYOCARDIAL INFARCTS OF RATS
Hill, J. H., & Ward, P. A. (1971) · The Journal of Experimental Medicine · doi:10.1084/jem.133.4.885 · Cited by 395
Self-citationThe Gut Origin Septic States in Blunt Multiple Trauma (ISS = 40) in the ICU
BORDER, J. R., HASSETT, J., LADUCA, J., SEIBEL, R., STEINBERG, S., MILLS, B., LOSI, P., & BORDER, D. (1987) · Annals of Surgery · doi:10.1097/00000658-198710000-00004 · Cited by 351
The C5a chemoattractant receptor mediates mucosal defence to infection
Höpken, U. E., Lu, B., Gerard, N. P., & Gerard, C. (1996) · Nature · doi:10.1038/383086a0 · Cited by 344
Risk of Infection after Penetrating Abdominal Trauma
Nichols, R. L., Smith, J. W., Klein, D. B., Trunkey, D. D., Cooper, R. H., Adinolfi, M. F., & Mills, J. (1984) · New England Journal of Medicine · doi:10.1056/nejm198410253111701 · Cited by 313
Cited by
The Pathophysiology and Treatment of Sepsis
Hotchkiss, R. S., & Karl, I. E. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021333 · Cited by 4,097
Hotchkiss, R. S., Moldawer, L. L., Opal, S. M., Reinhart, K., Turnbull, I. R., & Vincent, J.-L. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.45 · Cited by 1,620
Acute Renal Failure and Sepsis
Schrier, R. W., & Wang, W. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032401 · Cited by 1,260
Immune evasion by staphylococci
Foster, T. J. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1289 · Cited by 1,222
The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome
Aird, W. C. (2003) · Blood · doi:10.1182/blood-2002-06-1887 · Cited by 1,131
Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome
Bhatia, M., & Moochhala, S. (2004) · The Journal of Pathology · doi:10.1002/path.1491 · Cited by 1,095
Complement System Part II: Role in Immunity
Merle, N. S., Noe, R., Halbwachs-Mecarelli, L., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00257 · Cited by 1,051
ROLE OF C5A IN INFLAMMATORY RESPONSES
Guo, R.-F., & Ward, P. A. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115835 · Cited by 1,021
Self-citationThe immune system’s role in sepsis progression, resolution, and long-term outcome
Delano, M. J., & Ward, P. A. (2016) · Immunological Reviews · doi:10.1111/imr.12499 · Cited by 880
Self-citationCecal ligation and puncture: the gold standard model for polymicrobial sepsis?
Dejager, L., Pinheiro, I., Dejonckheere, E., & Libert, C. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.01.001 · Cited by 784
Novel strategies for the treatment of sepsis
Riedemann, N. C., Guo, R.-F., & Ward, P. A. (2003) · Nature Medicine · doi:10.1038/nm0503-517 · Cited by 773
Self-citationThe role of the anaphylatoxins in health and disease
Klos, A., Tenner, A. J., Johswich, K.-O., Ager, R. R., Reis, E. S., & Köhl, J. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.04.027 · Cited by 730
The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight
Markiewski, M. M., & Lambris, J. D. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070166 · Cited by 722
Kalogeris, T., Baines, C. P., Krenz, M., & Korthuis, R. J. (2016) · Comprehensive Physiology · doi:10.1002/cphy.c160006 · Cited by 718
Riedemann, N. C., Guo, R., & Ward, P. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19523 · Cited by 624
Self-citationSystemic inflammation after trauma
Lenz, A., Franklin, G. A., & Cheadle, W. G. (2007) · Injury · doi:10.1016/j.injury.2007.10.003 · Cited by 600
Host–pathogen interactions in sepsis
van der Poll, T., & Opal, S. M. (2008) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70265-7 · Cited by 553
Chemotaxis Inhibitory Protein of Staphylococcus aureus, a Bacterial Antiinflammatory Agent
de Haas, C. J. C., Veldkamp, K. E., Peschel, A., Weerkamp, F., Van Wamel, W. J. B., Heezius, E. C. J. M., Poppelier, M. J. J. G., Van Kessel, K. P. M., & van Strijp, J. A. G. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031636 · Cited by 471
Mollnes, T. E., Brekke, O., Fung, M. S. C., Fure, H., Christiansen, D., Bergseth, G., Videm, V., Lappegård, K. T., Köhl, J., & Lambris, J. D. (2002) · PubMed · doi:10.1182/blood.v100.5.1869.h81702001869_1869_1877 · Cited by 455
Tsuda, Y., Takahashi, H., Kobayashi, M., Hanafusa, T., Herndon, D. N., & Suzuki, F. (2004) · Immunity · doi:10.1016/j.immuni.2004.07.006 · Cited by 425
The dark side of C5a in sepsis
Ward, P. A. (2004) · Nature Reviews Immunology · doi:10.1038/nri1269 · Cited by 422
Self-citationThe disconnect between animal models of sepsis and human sepsis
Rittirsch, D., Hoesel, L. M., & Ward, P. A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806542 · Cited by 406
Self-citationFunctional roles for C5a receptors in sepsis
Rittirsch, D., Flierl, M. A., Nadeau, B. A., Day, D. E., Huber-Lang, M., Mackay, C. R., Zetoune, F. S., Gerard, N. P., Cianflone, K., Köhl, J., et al. (2008) · Nature Medicine · doi:10.1038/nm1753 · Cited by 386
Self-citationProtective Effects of IL-6 Blockade in Sepsis Are Linked to Reduced C5a Receptor Expression
Riedemann, N. C., Neff, T. A., Guo, R.-F., Bernacki, K. D., Laudes, I. J., Sarma, J. V., Lambris, J. D., & Ward, P. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.1.503 · Cited by 330
Self-citationTherapeutic effects of lysophosphatidylcholine in experimental sepsis
Yan, J.-J., Jung, J.-S., Lee, J.-E., Lee, J., Huh, S.-O., Kim, H.-S., Jung, K. C., Cho, J.-Y., Nam, J.-S., Suh, H.-W., et al. (2004) · Nature Medicine · doi:10.1038/nm989 · Cited by 329
Kopf, M., Abel, B., Gallimore, A., Carroll, M., & Bachmann, M. F. (2002) · Nature Medicine · doi:10.1038/nm0402-373 · Cited by 311
Hou, X., Zhang, X., Zhao, W., Zeng, C., Deng, B., McComb, D. W., Du, S., Zhang, C., Li, W., & Dong, Y. (2020) · Nature Nanotechnology · doi:10.1038/s41565-019-0600-1 · Cited by 290
Intravascular immunity: the host–pathogen encounter in blood vessels
Hickey, M. J., & Kubes, P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2532 · Cited by 251
Ehrnthaller, C., Ignatius, A., Gebhard, F., & Huber-Lang, M. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00149 · Cited by 226
Self-citationThiel, M., Caldwell, C. C., Kreth, S., Kuboki, S., Chen, P., Smith, P., Ohta, A., Lentsch, A. B., Lukashev, D., & Sitkovsky, M. V. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000853 · Cited by 175
Conroy, A., Serghides, L., Finney, C., Owino, S. O., Kumar, S., Gowda, D. C., Liles, W. C., Moore, J. M., & Kain, K. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004953 · Cited by 81
Evidence for anti‐inflammatory effects of C5a on the innate IL‐17A/IL‐23 axis
Bosmann, M., Sarma, J. V., Atefi, G., Zetoune, F. S., & Ward, P. A. (2012) · The FASEB Journal · doi:10.1096/fj.11-199216 · Cited by 67
Self-citationC5a anaphylatoxin and its role in critical illness-induced organ dysfunction
Wood, A. J. T., Vassallo, A., Summers, C., Chilvers, E. R., & Conway‐Morris, A. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13028 · Cited by 45
“Anti‐C5a antibodies have been employed for many years and have shown significant mortality benefits in animal sepsis models.(63,74,113) Despite such promising findings, the only licensed therapy which manipulates the C5a axis directly is eculizumab.”
BackgroundTherapeutic potential of targeting IL‐17 and IL‐23 in sepsis
Bosmann, M., & Ward, P. A. (2012) · Clinical and Translational Medicine · doi:10.1186/2001-1326-1-4 · Cited by 42
Self-citationCOVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspective
Cavaillon, J.-M., & Osuchowski, M. F. (2021) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2021.04.003 · Cited by 17
Tyrosine kinase inhibitor tyrphostin AG490 reduces liver injury in LPS-induced shock
Gyurkovska, V., & Ivanovska, N. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.01.045 · Cited by 11
Metadata
- Authors
- Czermak, B. J., Sarma, V., Pierson, C. L., Warner, R. L., Huber-Lang, M., Bless, N. M., Schmal, H., Friedl, H. P., & Ward, P. A.
- Venue
- Nature Medicine
- Published
- 1999-07
- Volume
- 5
- Issue
- 7
- Pages
- 788-792
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1592616574
- Cited by
- 404
- References
- 25
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.